Browsing by Author McNeil, Catriona

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 20 of 21  next >
Issue DateTitleAuthor(s)Citation
2009BAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breastMcNeil, Catriona; O'Toole, Sandra; Anderson, Luke R.; Biankin, Andrew V.; Butt, Alison Joy; Crea, P; Henshall, Susan M.; Millar, E.; Morey, Adrienne; Musgrove, Elizabeth A.; Pinese, Mark; Sutherland, Robert L.; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyBAG-1 predicts patient outcome and tamoxifen responsiveness in ER-positive invasive ductal carcinoma of the breast, British Journal of Cancer, vol.100, 1,pp 123-133
2017Clinical nurse consultant support: Management of patients with melanoma receiving immunotherapy and targeted therapyMcNeil, Catriona; Saw, Robyn; Honeyball, Florian X.; Lomax, Anna J.; Nielsen, Theresa; O'Carrigan, Brent; Shum, Benjamin; Visintin, Lydia; Central Clinical School: Medicine; Central Clinical School: SurgeryClinical nurse consultant support: Management of patients with melanoma receiving immunotherapy and targeted therapy, Clinical Journal of Oncology Nursing, vol.21, 4, 2017,pp E93-E98
2010Cytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients.McNeil, Catriona; O'Toole, Sandra; Crea, Paul; Lopez-Knowles, Elena; Millar, E.; Musgrove, Elizabeth A.; Sutherland, Robert L.; Zardawi, Sarah J; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyCytoplasmic localization of beta-catenin is a marker of poor outcome in breast cancer patients., Cancer Epidemiology, Biomarkers & Prevention, vol.19, 1,pp 301-309
2018Dose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trialsBeith, Jane; Boyer, Michael; Kao, Steven; McNeil, Catriona; Prasanna, Thiru; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineDose modifications in adjuvant chemotherapy for solid organ malignancies: A systematic review of clinical trials, Asia-Pacific Journal of Clinical Oncology, vol.14, 3, 2018,pp 125-133
2011Enhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancersMcNeil, Catriona; O'Toole, Sandra; Fox, Stephen B.; McKay, Michael J.; Millar, Ewan; Natrajan, Rachael; Patra, Jennifer; Ramsay, Robert G.; Reis-Filho, Jorge; Sutherland, Robert L.; Swagemakers, Sigrid; Tomaszewski, Jonathan M.; van der Spek, Peter; Verschoor, Sandra; Xu, Huiling; Yan, Max; Yan, Yuqian; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyEnhanced RAD21 cohesin expression confers poor prognosis and resistance to chemotherapy in high grade luminal, basal and HER2 breast cancers, Breast Cancer Research, vol.13, 1, 2011,pp R9-1-R9-36
2015Equivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testingCooper, Wendy Anne; Gill, Anthony; Pavlakis, Nick; Amanuel, Benhur; Christie, Michael; Diakos, Connie; Lum, Trina; McNeil, Catriona; Millward, Michael; Morey, Adrienne; O'Toole, Sandra; Peverall, Joanne; Selinger, Christina; Tran, Yen; Van Vliet, Chris; Waring, Paul; Central Clinical School: Medicine; Northern Clinical School: Pathology; Northern Clinical School: MedicineEquivocal ALK fluorescence in-situ hybridization (FISH) cases may benefit from ancillary ALK FISH probe testing, Histopathology, vol.67, 5, 2015,pp 654-663
2010High Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtypeHamilton, Anne; Lee, Cheok; McNeil, Catriona; Spillane, Andrew; Crea, P; Lopez-Knowles, Elena; McLeod, Duncan; Millar, Ewan; Morey, Adrienne; Murphy, N C; Musgrove, Elizabeth A.; Oakes, Samantha; Ormandy, Christopher J.; O'Toole, Sandra; Pinese, Mark; Qiu, Min; Sutherland, Robert L.; Zardawi, Ibrahim; Zardawi, Sarah J; Central Clinical School: Medicine; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Northern Clinical School: MedicineHigh Notch1 protein expression is an early event in breast cancer development and is associated with the HER-2 molecular subtype, Histopathology, vol.56, 3,pp 286-296
2011Identification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancerMcNeil, Catriona; O'Toole, Sandra; Butt, Alison Joy; Lehrbach, Gillian M.; McCloy, R. A.; Millar, E. K. A.; Musgrove, Elizabeth A.; Pinese, Mark; Roberts, C. G.; Sutherland, Robert L.; Tobelmann, P; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyIdentification of PUMA as an estrogen target gene that mediates the apoptotic response to tamoxifen in human breast cancer cells and predicts patient outcome and tamoxifen responsiveness in breast cancer, Oncogene: including Oncogene Reviews, vol.30, 28, 2011,pp 3186-3197
2018Immune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical ManagementChua, Elizabeth; Lowe, Patricia; McGill, Neil; McNeil, Catriona; Shackel, Nicholas; Sweeting, Arianne Natasha; Cheng, R; Lim, Jennifer; Lomax, Anna J.; Central Clinical School: Medicine; Anaesthesia; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Centenary Institute; Boden InstituteImmune Toxicity with Checkpoint Inhibition for Metastatic Melanoma: Case Series and Clinical Management, Journal of Skin Cancer, vol.2018, N/A, 2018,pp 9602540-N/A
2017Immunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysisChoi, Clara; Fazekas de St Groth, Barbara Denise; Hersey, Peter; Hollingsworth, Jane; Kim, Haewon; McGill, Neil; McGuire, Helen; McNeil, Catriona; Shannon, Kerwin; Van Hal, Sebastiaan; Carr, U; Crotty, A; Gupta, Sandeep; Karikios, D; Lomax, A; School of Public Health: Public Health; School of Medical Sciences: Pathology; Northern Clinical School: Surgery; School of Public Health: Public Health; School of Public Health: Public Health; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Medicine; Central Clinical School: MedicineImmunotherapy-induced sarcoidosis in patients with melanoma treated with PD-1 checkpoint inhibitors: Case series and immunophenotypic analysis, International Journal of Rheumatic Diseases, vol.20, 9, 2017,pp 1277-1285
2017Ipilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trialMcNeil, Catriona; Arance, A; Ascierto, Paolo A; Bastholt, Lars; Chiarion-Sileni, Vanna; Del Vecchio, Michele; et al, Various; Hamid, Omid; Lebbe, Celeste; Mackiewicz, Andrzej; Robert, Caroline; Rutkowski, Piotr; Central Clinical School: MedicineIpilimumab 10 mg/kg versus ipilimumab 3 mg/kg in patients with unresectable or metastatic melanoma: a randomised, double-blind, multicentre, phase 3 trial, The Lancet Oncology, vol.18, 5, 2017,pp 611-622
2015Ipilimumab-induced toxicities and the gastroenterologistKench, James; McNeil, Catriona; Shackel, Nicholas; Bye, William; Cheng, Robert; Cooper, Adam; Watson, Geoffrey; School of Medical Sciences: Pathology; Western Clinical School: Medicine (Westmead); Central Clinical School: Centenary InstituteIpilimumab-induced toxicities and the gastroenterologist, Journal of Gastroenterology and Hepatology, vol.30, 4, 2015,pp 657-666
2010Loss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative statusMcNeil, Catriona; O'Toole, Sandra; Biankin, Andrew V.; Crea, Paul; et al, various; Fox, Stephen B.; Lee, Cheok; Millar, E.; Murphy, Niamh; Olayioye, Monilola; Segara, Davendra; Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyLoss of STARD10 expression identifies a group of poor prognosis breast cancers independent of HER2/Neu and triple negative status, International Journal of Cancer, vol.126, 6,pp 1445-1453
2015MicroRNA-Related DNA repair/ cell-cycle genes independently associated with relapse after radiation therapy for early breast cancerBeith, Jane; Carmalt, Hugh; Cooper, Caroline; Gee, Harriet; Kennedy, Catherine Jane; McNeil, Catriona; O'Toole, Sandra; Beckers, Rhiannon; Buffa, Francesca; Carroll, Susan L; et al, Various; Harris, Adrian L.; Holliday, Anne; Mak, Cindy; Selinger, Christina; Toohey, Joanne; Warrier, Sanjay; Central Clinical School: Medicine; Concord Clinical School: Surgery; Central Clinical School: Pathology; Central Clinical School: Medicine; Western Clinical School: Medicine (Westmead); Western Clinical School: Medicine (Westmead); Central Clinical School: PathologyMicroRNA-Related DNA repair/ cell-cycle genes independently associated with relapse after radiation therapy for early breast cancer, International Journal of Radiation Oncology: Biology Physics, vol.93, 5, 2015,pp 1104-1114
2015Nivolumab in Previously Untreated Melanoma without BRAF MutationLong, Georgina; Brady, Ben; Dutriaux, Caroline; et al, Various; Hassel, Jessica; Hernberg, Micaela; Kalinka-Warzocha, Ewa; Maio, Michele; McNeil, Catriona; Mortier, Laurent; Robert, Caroline; Rutkowski, Piotr; Savage, Kerry; Central Clinical School: The Sydney Cancer CentreNivolumab in Previously Untreated Melanoma without BRAF Mutation, The New England Journal of Medicine, vol.372, 4, 2015,pp 320-330
2016Outcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien LifehouseBeith, Jane; Bhadri, Vivek; Boyer, Michael; Grimison, Peter; Horvath, Lisa; Kao, Steven; McNeil, Catriona; Tattersall, Martin; Lomax, Anna; Thomas, David; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; NH&MRC Clinical Trials Centre; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: Medicine; Central Clinical School: MedicineOutcomes of patients with non-melanoma solid tumours receiving self-funded pembrolizumab at Chris O'Brien Lifehouse, Internal Medicine Journal, vol.46, 12, 2016,pp 1392-1398
2015Pembrolizumab versus ipilimumab in advanced melanomaCarlino, Matteo; Long, Georgina; Arance, Ana; Daud, Adil; et al, Various; Grob, Jean Jacques; Larkin, James; Lorigan, Paul; Lotem, Michal; McNeil, Catriona; Mortier, Laurent; Neyns, Bart; Robert, Caroline; Schachter, Jacob; Western Clinical School: Medicine (Westmead); Central Clinical School: The Sydney Cancer CentrePembrolizumab versus ipilimumab in advanced melanoma, The New England Journal of Medicine, vol.372, 26, 2015,pp 2521-2532
2010PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortalityO'Toole, Sandra; Crea, Paul; Daly, Roger; Lopez-Knowles, Elena; McNeil, Catriona; Millar, E.; Musgrove, Elizabeth A.; Qiu, Min Ru; Sutherland, Robert L.; Central Clinical School: PathologyPI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality, International Journal of Cancer, vol.126, 5,pp 1121-1131
2018Programmed cell death-1 (PD-1) contributes to the establishment and maintenance of HIV-1 latencyGarsia, Roger; Palmer, Sarah; Cameron, Paul U; Chomont, Nicolas; Dantanarayana, Ashanti; Evans, Vanessa A; Fromentin, Remi; Lewin, Sharon R.; McNeil, Catriona; Sekaly, Rafick-Pierre; Solomon, Ajantha; van der Sluis, Renee M; Central Clinical School: Medicine; Westmead Clinical School: Westmead Institute for Medical ResProgrammed cell death-1 (PD-1) contributes to the establishment and maintenance of HIV-1 latency, AIDS, vol.32, 11, 2018,pp 1491-1497
2016Programmed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcomeBeith, Jane; Carmalt, Hugh; Chan, Charles; Cooper, Caroline; Gee, Harriet; Gillett, David; Gluch, Laurence; Kennedy, Catherine; McLean, Anna; McNeil, Catriona; O'Toole, Sandra; Scolyer, Richard; Vilain, Ricardo; Walker, Emily; Warrier, Sanjay; Wilmott, James; Beckers, Rhiannon; Harvey, Kate; Holliday, Anne; Madore, Jason; Mak, Cindy; Robbins, Elizabeth; Selinger, Christina; Swarbrick, A.; Central Clinical School: Medicine; Concord Clinical School: Surgery; Concord Clinical School: Medicine; Central Clinical School: Pathology; Central Clinical School: Medicine; Concord Clinical School: Surgery; Central Clinical School: Medicine; Central Clinical School: Surgery; Northern Clinical School: Rehabilitations Studies Unit; Western Clinical School: Medicine (Westmead); Central Clinical School: Pathology; Central Clinical School: Pathology; Central Clinical School: Pathology; Medicine; Central Clinical School: Surgery; Central Clinical School: SurgeryProgrammed death ligand 1 expression in triple-negative breast cancer is associated with tumour-infiltrating lymphocytes and improved outcome, Histopathology, vol.69, 1, 2016,pp 25-34